21 Aug 2020
Kadcyla (Trastuzumab emtansine, Tubulin polymerization inhibitor; Chugai (a Roche subsidiary)/Immunogen)
Our outlook:
– Dr. Kowndinya, CI Scientists
Background:
To read original article click here
info@ciscientists.com
For a subscription, please provide your email id